Fall 2005 Volume 6, Issue 6:
Making Clinical Trials More Patient-Friendly
By A Special Report by
The Unknown Patient
All new cancer drugs must be proven safe and effective in clinical trials before they can be made available to patients. At the 2005 IMF Support Group Leader Retreat, IMFer and leader of the Manhattan and White Plains (New York) myeloma support group
|
step 1: get the correct diagnosis
publications
back
print
related articles
Be the first to comment